Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro–in vivo correlation

References

• Corsonello A, Pedone C, Incalzi RA. (2010). Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 17:571–84
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
   PubMed Web of Science ®Google Scholar
• Gorski J. (2003). The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Clin Pharmacol Ther 74:275–87
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Abernethy DR, Locniskar A, et al. (1984). Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 61:27–35
   PubMed Web of Science ®Google Scholar
• Harper KW, Collier PS, Dundee JW, et al. (1985). Age and nature of operation influence the pharmacokinetics of midazolam. Br J Anaesth 57:866–71
   PubMed Web of Science ®Google Scholar
• Hosoi Y, Uno Y, Murayama N, et al. (2012). Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation. Biochem Pharmacol 84:1691–5
   PubMed Web of Science ®Google Scholar
• Houston JB. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469–79
   PubMed Web of Science ®Google Scholar
• Ishizawa Y, Yasui-Furukori N, Takahata T, et al. (2005). The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clin Pharmacokinet 44:1179–89
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Murayama N, Koizumi R, et al. (2010). Comparison of cytochrome P450 3A enzymes in cynomolgus monkeys and humans. Drug Metab Pharmacokinet 25:388–91
   PubMed Web of Science ®Google Scholar
• Jensen BP, Chin PK, Roberts RL, Begg EJ. (2012). Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin. Br J Clin Pharmacol 74:797–805
   PubMed Web of Science ®Google Scholar
• Johnson JA, Burlew BS. (1996). Metoprolol metabolism via cytochrome P4502D6 in ethnic populations. Drug Metab Dispos 24:350–5
   PubMed Web of Science ®Google Scholar
• Klotz U. (2009). Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67–76
   PubMed Web of Science ®Google Scholar
• Klotz U, Schwab M, Treiber G. (2004). CYP2C19 polymorphism and proton pump inhibitors. Basic Clin Pharmacol Toxicol 95:2–8
   PubMed Web of Science ®Google Scholar
• Koyanagi T, Yamaura Y, Yano K, et al. (2014). Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs. Xenobiotica 44:893–901
   PubMed Web of Science ®Google Scholar
• Larsson M, Landahl S, Lundborg P, Regardh CG. (1984). Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol 27:217–22
   PubMed Web of Science ®Google Scholar
• McLachlan AJ, Pont LG. (2012). Drug metabolism in older people – a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci 67:175–80
   PubMed Web of Science ®Google Scholar
• Mogi M, Toda A, Iwasaki K, et al. (2012). Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs. J Toxicol Sci 37:1157–64
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Terashita S, Kimura S, et al. (2001). Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab Dispos 29:1316–24
   PubMed Web of Science ®Google Scholar
• Obach RS, Lombardo F, Waters NJ. (2008). Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 36:1385–405
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, et al. (2004). The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193–209
   PubMed Web of Science ®Google Scholar
• Platten HP, Schweizer E, Dilger K, et al. (1998). Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther 63:552–60
   PubMed Web of Science ®Google Scholar
• Rendic S, Guengerich FP. (2012). Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316–83
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kashima T, Nomoto S, et al. (1998). Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes. Pharmacogenetics 8:365–73
   PubMedGoogle Scholar
• Turpault S, Brian W, Van Horn R, et al. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928–35
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654–61
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Kohara S, et al. (2010). Cynomolgus monkey CYP2D44 newly identified in liver, metabolizes bufuralol, and dextromethorphan. Drug Metab Dispos 38:1486–92
   PubMed Web of Science ®Google Scholar
• Uno Y, Matsushita A, Murayama N, Yamazaki H. (2014a). Genetic polymorphism of cynomolgus and rhesus macaque CYP2C9. Drug Metab Pharmacokinet. [in press]. DOI: 10.1016/j.dmpk.2014.10.002
   Google Scholar
• Uno Y, Matsushita A, Shukuya M, et al. (2014b). CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques. Biochem Pharmacol 91:242–8
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Kohara S, et al. (2014c). Polymorphisms of CYP2D17 in cynomolgus and rhesus macaques: an evidence of the genetic basis for the variability of CYP2D-dependent drug metabolism. Drug Metab Dispos 42:1407–10
   PubMed Web of Science ®Google Scholar
• Utoh M, Murayama N, Uno Y, et al. (2013). Monkey liver cytochrome P450 2C9 is involved in caffeine 7-N-demethylation to form theophylline. Xenobiotica 43:1037–42
   PubMed Web of Science ®Google Scholar
• Viani A, Rizzo G, Carrai M, Pacifici GM. (1992). The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br J Clin Pharmacol 33:299–304
   PubMed Web of Science ®Google Scholar